본문 바로가기
KERD
논문KCI 등재

비알코올성 지방간 세포 모델에서 곤포의 효능과 기전 연구

Research on Anti-lipogenic Effect and Underlying Mechanism of Laminaria japonica on Experimental Cellular Model of Non-alcoholic Fatty Liver Disease

3

조회

0

다운로드

11

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives : We tried to uncover the anti-lipogenic effect and underlying mechanism of Laminaria japonica on an experimental cellular model of non-alcoholic fatty liver disease. Methods : Ethanol extract of Laminaria japonica (LJ) was prepared. Intracellular lipid content of palmitate-treated HepG2 cells was evaluated with or without LJ treatment. We measured the effects of LJ on liver X receptor α (LXRα) and sterol regulatory element-binding transcription factor-1c (SREBP-1c) expression, transcription level of lipogenic genes, including acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), stearoyl-CoA desaturase-1 (SCD-1), and nuclear factor erythroid 2-related factor 2 (Nrf2) activation in HepG2 cells. Results : LJ markedly attenuated palmitate-induced intracellular lipid accumulation in HepG2 cells. LJ suppressed LXRα-dependent SREBP-1c activation, and SREBP-1c mediated induction of ACC, FAS, and SCD-1. Furthermore, LJ activated Nrf2, which plays an important cytoprotective role in non-alcoholic fatty liver disease. Conclusions : Our study suggests that LJ has the potential to alleviate hepatic lipid accumulation, and this effect was mediated by inhibiting the LXRα-SREBP-1c pathway that leads to hepatic steatosis. In addition, the anti-lipogenic potential may, at least in part, be associated with activation of Nrf2.

Abstract

Objectives : We tried to uncover the anti-lipogenic effect and underlying mechanism of Laminaria japonica on an experimental cellular model of non-alcoholic fatty liver disease. Methods : Ethanol extract of Laminaria japonica (LJ) was prepared. Intracellular lipid content of palmitate-treated HepG2 cells was evaluated with or without LJ treatment. We measured the effects of LJ on liver X receptor α (LXRα) and sterol regulatory element-binding transcription factor-1c (SREBP-1c) expression, transcription level of lipogenic genes, including acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), stearoyl-CoA desaturase-1 (SCD-1), and nuclear factor erythroid 2-related factor 2 (Nrf2) activation in HepG2 cells. Results : LJ markedly attenuated palmitate-induced intracellular lipid accumulation in HepG2 cells. LJ suppressed LXRα-dependent SREBP-1c activation, and SREBP-1c mediated induction of ACC, FAS, and SCD-1. Furthermore, LJ activated Nrf2, which plays an important cytoprotective role in non-alcoholic fatty liver disease. Conclusions : Our study suggests that LJ has the potential to alleviate hepatic lipid accumulation, and this effect was mediated by inhibiting the LXRα-SREBP-1c pathway that leads to hepatic steatosis. In addition, the anti-lipogenic potential may, at least in part, be associated with activation of Nrf2.

참고문헌 (23)

  1. Sourianarayanane A, "Management of non-alcoholic fatty liver disease", Minerva Gastroenterol Dietol, 59(1), pp.69~87 (2013)
  2. Masuoka HC, "Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals", Ann NY Acad Sci, 1281, pp.106~122 (2013)
  3. Beaton MD, "Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis", Can J Gastroenterol, 26(6), pp.353~357 (2012)
  4. Shi KQ, "Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis", Mol Biol Rep, 39(10), pp.9715~9722 (2012)
  5. 김윤수, "다시마 열수추출물의 성분 및 항산화활성 측정", KSBB Journal, 26(2), pp.112~118 (2011), 한국생물공학회
  6. Hasani-Ranjbar S, "A systematic review of anti-obesity medicinal plants - an update", J Diabetes Metab Disord, 12(1), pp.28~ (2013)
  7. Huh J, "Donguibogam", pp.745~ (1999), Beobin Press
  8. Repa JJ, "Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta", Genes Dev, 14(22), pp.2819~2830 (2000)
  9. Bataille AM, "Nrf2: a potential target for new therapeutics in liver disease", Clin Pharmacol Ther, 92(3), pp.340~348 (2012)
  10. Pettinelli P, "Molecular mechanisms of steatosis in nonalcoholic fatty liver disease", Nutr Hosp, 26(3), pp.441~450 (2011)
  11. Kay HY, "Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.", ANTIOXIDANTS & REDOX SIGNALING, 15(8), pp.2135~2146 (2011), MARY ANN LIEBERT INC
  12. Browning JD, "Molecular mediators of hepatic steatosis and liver injury", J Clin Invest, 114(2), pp.147~152 (2004)
  13. Wu JN, "An illustrated Chinese materia medica", pp.368~369 (2005), Oxford University Press
  14. Miyata M, "Anti-obesity effect on rodents of the traditional Japanese food, tororokombu, shaved Laminaria", Biosci Biotechnol Biochem, 73(10), pp.2326~2328 (2009)
  15. Shirosaki M, "Laminaria japonica as a food for the prevention of obesity and diabetes", Adv Food Nutr Res, 64, pp.199~212 (2011)
  16. Li X, "Hypoglycemic Effect of Laminaria japonica Polysaccharide in a Type 2 Diabetes Mellitus Mouse Model", ISRN Endocrinol, 2012, pp.507462~ (2012)
  17. Jin DQ, "Preventive effects of Laminaria japonica aqueous extract on the oxidative stress and xanthine oxidase activity in streptozotocin-induced diabetic rat liver", BIOLOGICAL & PHARMACEUTICAL BULLETIN, 27(7), pp.1037~1040 (2004), PHARMACEUTICAL SOC JAPAN
  18. "Zhong Yao Cai", 2005, 676~679
  19. "Zhong Yao Cai", 2010, 1795~1798
  20. Laffitte BA, "Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue", Proc Natl Acad Sci USA, 100(9), pp.5419~5424 (2003)
  21. 이은경, "핵수용체의 대사 조절", Endocrinology and Metabolism, 23(3), pp.155~164 (2008), 대한내분비학회
  22. Copple IM, "The Keap1-Nrf2 cell defense pathway--a promising therapeutic target", Adv Pharmacol, 63, pp.43~79 (2012)
  23. Chowdhry S, "Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis", Free Radic Biol Med, 48(2), pp.357~371 (2010)

이 간행물의 다른 논문 (8건)